Theravance Biopharma, Inc. (TBPH)

16.26 -0.15 (-0.91%) USD  |  NASDAQ  |  May 27, 16:00
16.00 -0.26 (-1.60%) After-Hours: 20:00
More

Theravance Biopharma Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Viatris, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade